Valdebenito-Navarrete, H.; Fuentes-Barrera, V.; Smith, C.T.; Salas-Burgos, A.; Zuniga, F.A.; Gomez, L.A.; GarcÃa-Cancino, A.
Can Probiotics, Particularly Limosilactobacillus fermentum UCO-979C and Lacticaseibacillus rhamnosus UCO-25A, Be Preventive Alternatives against SARS-CoV-2? Biology 2023, 12, 384.
https://doi.org/10.3390/biology12030384
AMA Style
Valdebenito-Navarrete H, Fuentes-Barrera V, Smith CT, Salas-Burgos A, Zuniga FA, Gomez LA, GarcÃa-Cancino A.
Can Probiotics, Particularly Limosilactobacillus fermentum UCO-979C and Lacticaseibacillus rhamnosus UCO-25A, Be Preventive Alternatives against SARS-CoV-2? Biology. 2023; 12(3):384.
https://doi.org/10.3390/biology12030384
Chicago/Turabian Style
Valdebenito-Navarrete, Héctor, Victor Fuentes-Barrera, Carlos T. Smith, Alexis Salas-Burgos, Felipe A. Zuniga, Leonardo A. Gomez, and Apolinaria GarcÃa-Cancino.
2023. "Can Probiotics, Particularly Limosilactobacillus fermentum UCO-979C and Lacticaseibacillus rhamnosus UCO-25A, Be Preventive Alternatives against SARS-CoV-2?" Biology 12, no. 3: 384.
https://doi.org/10.3390/biology12030384
APA Style
Valdebenito-Navarrete, H., Fuentes-Barrera, V., Smith, C. T., Salas-Burgos, A., Zuniga, F. A., Gomez, L. A., & GarcÃa-Cancino, A.
(2023). Can Probiotics, Particularly Limosilactobacillus fermentum UCO-979C and Lacticaseibacillus rhamnosus UCO-25A, Be Preventive Alternatives against SARS-CoV-2? Biology, 12(3), 384.
https://doi.org/10.3390/biology12030384